Other Cancers

PPV increased to as much as 44.6% with combined-biomarker screening of high-risk patients

A year of DOAC therapy did not result in significantly more bleeds in ONCO DVT trial

A series of articles look at whether the benefits for the few warrant the harms for the many

News, features, and commentary about cancer-related issues

Time between symptom onset and diagnosis was 21% longer, study shows

Studies show their potential, but reveal clear issues with treatment information reliability

Crystal Denlinger, MD, succeeds Robert Carlson, MD, as CEO of the NCCN

Also in TTHealthWatch: alcohol consumption after a cancer diagnosis

News, features, and commentary about cancer-related issues

Immunotherapy in particular linked with 45% higher risk of VTE in hospitalized patients

Experts will discuss the chemotherapy drug shortages and the impact on patients

A 49-year-old woman visited her doctor concerned about a lesion that developed over her right toe within the last 4 weeks. Can you diagnose the patient?

Government response is "completely unacceptable," says co-chair of congressional PFAS Task Force

High prevalence of exceeding moderate drinking, binge drinking, hazardous drinking behavior